Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Open in API
Filings indexed 973 across all filing types
Latest filing 2026-05-28 Board/Management Inform…
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes Technologies Strengthens Board with Appointment of Dr. Hanna Pirita Lesch, Supporting Diversification into RNA and Continued Leadership in Cell & Gene Therapy - Attachment: ArcticZymes_Boa
Board/Management Information Classification · 95% confidence The document is a company announcement detailing changes in the board of directors (appointment of a new director, re-elections, and a resignation). This clearly fits the Board/Management Information category rather than an AGM presentation, annual report, or voting results announcement.
2026-05-28 English
ArcticZymes Technologies Strengthens Board with Appointment of Dr. Hanna Pirita Lesch, Supporting Diversification into RNA and Continued Leadership in Cell & Gene Therapy
Board/Management Information Classification · 95% confidence The document is a press release announcing changes to the company's Board of Directors: election of Dr. Hanna Pirita Lesch, re-election of the Chair and a Board member, and the stepping down of another member. This falls squarely under announcements of board composition changes, matching the “Board/Management Information” category.
2026-05-28 English
ArcticZymes Technologies ASA - Minutes form Annual General Meeting 2026 - Attachment: Minutes_of_AGM_AZT_2026.pdf
AGM Information Classification · 85% confidence The document is the official minutes (protokoll) of the Annual General Meeting of ArcticZymes Technologies ASA held on May 28, 2026. It contains the agenda, shareholder approvals, resolutions passed (including election of board members, authorisations for share issues and share buybacks, approval of annual report and financial statements, auditor remuneration, etc.). These minutes are materials from the AGM itself and record the decisions made at that meeting. This aligns exactly with the definition of AGM Information (Code: AGM-R), which covers presentations and materials shared during the Annual General Meeting. It is not a full annual report or regulatory announcement, but the meeting minutes themselves.
2026-05-28 Norwegian Bokmål
ArcticZymes Technologies ASA - Minutes form Annual General Meeting 2026
Report Publication Announcement Classification · 88% confidence The document is a brief announcement (under 5,000 characters) stating that the minutes of the Annual General Meeting are attached, rather than containing the minutes themselves or substantive content. Per the “menu vs. meal” rule, this is a report publication announcement rather than the AGM minutes document itself.
2026-05-28 English
ArcticZymes Technologies ASA - flagging av fullmakter
Declaration of Voting Results & Voting Rights Announcements Classification · 75% confidence The document is an announcement relating to the number of voting rights/proxies (fullmakter) received for the upcoming ordinary general meeting. It is not a report itself but an official notice of represented votes (voting rights), fitting the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-05-27 Norwegian Bokmål
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum - Attachment: AZT_Q1_2026_Press_release.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of first-quarter 2026 financial results for ArcticZymes Technologies, including sales growth, EBITDA figures, segment performance, CEO commentary, and outlook. It contains specific quarterly financial data and analysis, such as revenue, EBITDA, and segment breakdowns, which are characteristic of an Interim / Quarterly Report. The presence of a webcast presentation announcement does not change the nature of the document, which is a comprehensive quarterly financial report. The document length (4817 characters) is sufficient to contain substantive financial data, not just a brief announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-07 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.